NCT04492813View on ClinicalTrials.gov

Plasmatic Concentrations of Propofol and Remifentanil in Obese and Non Obese Patients.

NACompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

December 20, 2018

Primary Completion Date

January 25, 2021

Study Completion Date

May 25, 2021

Conditions
General AnesthesiaObesity
Interventions
DRUG

Pharmacokinetic of propofol and remifentanil

Pharmacokinetic of propofol and remifentanil in both population: Obese and non Obese patients

Trial Locations (1)

63000

Service d'Anesthésie-Réanimation, Pôle Médecine Périopératoire - Hôpital Estaing, CHU de Clermont-Ferrand, Clermont-Ferrand

All Listed Sponsors
lead

University Hospital, Clermont-Ferrand

OTHER

NCT04492813 - Plasmatic Concentrations of Propofol and Remifentanil in Obese and Non Obese Patients. | Biotech Hunter | Biotech Hunter